
Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK
Keywords: VEC; valve endothelial cells; EndMT; endothelial to mesenchymal transformation; TGFβ; transforming growth factor-β; CAEC; carotid artery endothelial cells; α-SMA; α-smooth muscle actin; AT1; angiotensin II type 1 receptor; AT2; angiotensin II type 2 r